Cerebral Arterial Diseases — Hemodynamic and Functional Characteristics of the Cerebral Circulation in Obesity
Citation(s)
Fantuzzi G, Mazzone T Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol. 2007 May;27(5):996-1003. doi: 10.1161/ATVBAHA.106.131755. Epub 2007 Feb 15.
Foerstl H, Biedert S, Hewer W Multiinfarct and Alzheimer-type dementia investigated by transcranial Doppler sonography. Biol Psychiatry. 1989 Oct;26(6):590-4. doi: 10.1016/0006-3223(89)90084-x.
Frosen J, Joutel A Smooth muscle cells of intracranial vessels: from development to disease. Cardiovasc Res. 2018 Mar 15;114(4):501-512. doi: 10.1093/cvr/cvy002.
Ghorbani A, Ahmadi MJ, Shemshaki H The value of transcranial Doppler derived pulsatility index for diagnosing cerebral small-vessel disease. Adv Biomed Res. 2015 Feb 17;4:54. doi: 10.4103/2277-9175.151574. eCollection 2015.
Harris S, Reyhan T, Ramli Y, Prihartono J, Kurniawan M Middle Cerebral Artery Pulsatility Index as Predictor of Cognitive Impairment in Hypertensive Patients. Front Neurol. 2018 Jul 20;9:538. doi: 10.3389/fneur.2018.00538. eCollection 2018.
Hubert HB, Feinleib M, McNamara PM, Castelli WP Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983 May;67(5):968-77. doi: 10.1161/01.cir.67.5.968.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
